Clinical Trials Logo
  1. Home
  2. Rhinovirus
  3. NCT01175226

A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection — RHINO  

Rhinovirus Clinical Trial

Official title:
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Clinical Trial Summary

This study aims to evaluate the safety, tolerability and effectiveness of BTA798 on

- shortening the length and reducing the symptoms of human rhinovirus infection (also known as the common cold),

- controlling asthma symptoms, and

- lowering the risk of asthma symptoms worsening in subjects with asthma.

Clinical Trial Description

Subjects with a previous diagnosis of asthma will be pre screened within 90 days prior to enrolment. If a subject develops symptoms of human rhinovirus (HRV) infection they will visit the site for assessment. Symptomatic subjects meeting all eligibility criteria will be invited to enroll. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01175226
Study type Interventional
Source Vaxart
Contact
Status Completed
Phase Phase 2
Start date August 2010
Completion date March 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT02984280 - Specific Respiratory Infections as Triggers of Acute Medical Events N/A
Completed NCT01158560 - A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections Phase 3
Completed NCT03605862 - Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection Phase 3
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Not yet recruiting NCT05348707 - Impact of Covid-19 on Rhinovirus Epidemic
Not yet recruiting NCT05348616 - Impact of the Covid-19 on RSV
Recruiting NCT04489381 - Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection Phase 3
Completed NCT04670627 - Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics
Suspended NCT03508479 - Study of Airway Inflammatory Responses to Experimental Rhinovirus Infection Phase 1
Not yet recruiting NCT05348655 - Impact of the Covid-19 on RSV Epidemic in the Metropolis of Lyon
Completed NCT02438293 - 'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery'
Completed NCT05016687 - First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers. Phase 1
Completed NCT02660489 - Effect of OC459 on the Response to Rhinovirus Challenge in Asthma Phase 2
Completed NCT02522832 - Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge N/A
Completed NCT01302418 - Collection and Testing of Respiratory Samples N/A
Completed NCT01249625 - The Respiratory Protection Effectiveness Clinical Trial N/A
Completed NCT00394914 - Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295) Phase 2
Withdrawn NCT03024177 - A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection Phase 2